Aaron Broadwell is a Rheumatology/Immunology physician affiliated with Louisiana State University in Shreveport. OpenAlex indexes 21 publications with 260 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
820 Jordan St
Suite 201
Shreveport, LA 711014518
Telephone
318-221-0399Registry record last updated 21 Aug 2012.
Industry payments
46 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202557 payments$49,848openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202592 payments$41,203openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202557 payments$16,586openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
83.7%TNF inhibitor60.4%Golimumab74%Certolizumab pegol25%Infliximab1%Enbrel Sureclick0%Humira(Cf) Pen0%Simponi0%Enbrel Mini0%Remicade0%Cimzia (2 Pack)0%Part D + Part B<11 patientsInterleukin-6 Receptor Antagonist13.9%Tocilizumab100%Actemra0%Kevzara0%Part D + Part B<11 patients+ 6 more classes in this area
Musculoskeletal
15.9%RANK Ligand Inhibitor8.5%Denosumab100%Prolia0%Part D + Part B≥492 patientsOther drugs affecting bone structure and mineralization7.3%Romosozumab-aqqg100%Part B, office-administered≥52 patients+ 2 more classes in this area
Dermatology
0.3%Corticosteroid0.3%Methylprednisolone sodium succinate56%Triamcinolone acetonide44%Part B, office-administered≥108 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Abreo, MBBS
Louisiana State University in Shreveport
Mahmoud Dibas, MD
Louisiana State University in Shreveport
Bharat Guthikonda
Louisiana State University in Shreveport
Kalgi Modi, MD
Louisiana State University in Shreveport
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”